Related Experiment Videos
Management of purulent pericarditis
W Z Tomkowski1, P Kuca, R Gralec
1Intensive Care Unit, National Tuberculosis and Lung Diseases Research Institute, 01-138 Warsaw, Plocka 26, Poland. w.tomkowski@igichp.edu.pl
Summary
This case study highlights successful treatment of purulent pericarditis using intrapericardial streptokinase. The innovative approach effectively resolved severe pericardial fluid drainage, preventing constrictive pericarditis.
Area of Science:
- Infectious Diseases
- Cardiology
- Thoracic Surgery
Background:
- Purulent pericarditis is a rare but serious condition often associated with other infections.
- Prompt diagnosis and aggressive management are crucial for patient survival and preventing complications like constrictive pericarditis.
Observation:
- A 50-year-old male presented with purulent pericarditis, mediastinitis, and pneumonia, requiring subxyphoid pericardiotomy and multiple drains.
- Despite initial antibiotic therapy and surgical drainage, persistent large-volume purulent pericardial effusion was observed.
Findings:
- Intrapericardial administration of streptokinase led to an excellent clinical response, rapidly decreasing purulent pericardial fluid drainage.
- Within 17 days, purulent pericardial fluid drainage ceased, and subsequent echocardiography revealed no signs of constrictive pericarditis or residual effusion.
Implications:
- Intrapericardial streptokinase can be a highly effective adjunctive therapy for managing refractory purulent pericarditis with significant effusion.
- This case underscores the importance of considering novel treatment strategies for complex infectious pericardial diseases to improve patient outcomes.